CN106854174A - A kind of preparation method of 4 substituted piperidine derivatives - Google Patents

A kind of preparation method of 4 substituted piperidine derivatives Download PDF

Info

Publication number
CN106854174A
CN106854174A CN201510899842.XA CN201510899842A CN106854174A CN 106854174 A CN106854174 A CN 106854174A CN 201510899842 A CN201510899842 A CN 201510899842A CN 106854174 A CN106854174 A CN 106854174A
Authority
CN
China
Prior art keywords
prepare compound
reaction
reaction prepare
solvent
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510899842.XA
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huateng Pharmaceutical Co Ltd
Original Assignee
Hunan Huateng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huateng Pharmaceutical Co Ltd filed Critical Hunan Huateng Pharmaceutical Co Ltd
Priority to CN201510899842.XA priority Critical patent/CN106854174A/en
Publication of CN106854174A publication Critical patent/CN106854174A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Abstract

The invention discloses a kind of 4 preparation methods of substituted pyridine compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates, with the bromo- Benzaldehyde,2-hydroxies of 5- as initiation material, target product is obtained by oximate, elimination, etherificate, catalytic hydrogenation reaction, the compound is important medicine intermediate.

Description

A kind of preparation method of 4 substituted piperidine derivatives
Technical field
The present invention relates to a kind of novel processing step of medicine intermediate, more particularly to a kind of 4 preparation methods of substituted pyridine compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates.
Technical background
4 substituted pyridine compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates, structural formula is:
The derivative of this compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates and correlation has extensive use in pharmaceutical chemistry and organic synthesis.The synthesis of current 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates is more difficult.Accordingly, it would be desirable to develop a raw material be easy to get, it is easy to operate, react easily controllable, the suitable synthetic method of overall yield.
The content of the invention
The invention discloses a kind of 4 preparation methods of substituted pyridine compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates, with the bromo- Benzaldehyde,2-hydroxies of 5- as initiation material, target product 5 is obtained by oximate, elimination, etherificate, catalytic hydrogenation reaction.Synthesis step is as follows:
(1) with the bromo- Benzaldehyde,2-hydroxies of 5- as initiation material, 2 are obtained by oximation reaction;
(2) elimination reaction is carried out 2, obtains 3;
(3) carry out etherification reaction 3 and obtain 4;
(4) carry out catalytic hydrogenation reaction 4 and obtain 5;
One preferred embodiment in, reagent used by described oximation reaction prepare compound 2 is selected from hydroxylamine hydrochloride;Reagent used by described elimination reaction prepare compound 3 is selected from acetic anhydride;Reagent used by described etherification reaction prepare compound 4 is selected from 4- (hydroxymethyl) piperidines -1- t-butyl formates;Catalyst used by described catalytic hydrogenation reaction prepare compound 5 is selected from palladium carbon.
One preferred embodiment in, solvent used by described oximation reaction prepare compound 2 is selected from ethanol;Solvent used by described elimination reaction prepare compound 3 is selected from acetic anhydride;Solvent used by described etherification reaction prepare compound 4 is selected from tetrahydrofuran;Solvent used by described catalytic hydrogenation reaction prepare compound 5 is selected from methyl alcohol.
One preferred embodiment in, the reaction temperature used by described oximation reaction prepare compound 2 is room temperature;Temperature used by described elimination reaction prepare compound 3 is the reflux temperature of solvent;Temperature used by described etherification reaction prepare compound 4 is room temperature;Temperature used by described catalytic hydrogenation reaction prepare compound 5 is room temperature.
The present invention relates to a kind of 4 preparation methods of the preparation method of substituted pyridine compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates, currently without other Patents documents report.
The present invention is further described by the following embodiment, and these descriptions are not that present invention is further limited.It should be understood by those skilled in the art that the equivalent made to technical characteristic of the invention, or be correspondingly improved, still fall within protection scope of the present invention.
Specific embodiment mode
Embodiment 1
(1) synthesis of the bromo- Benzaldehyde,2-hydroxy oximes of 5-
The bromo- Benzaldehyde,2-hydroxies of 30g 5- are added in 270ml ethanol, 17g hydroxylamine hydrochlorides are added dropwise to, is stirred overnight at room temperature, cooled down, add water and ethyl acetate, extraction point liquid to collect organic phase, dry, concentration obtains the bromo- Benzaldehyde,2-hydroxy oximes of 23g 5-.
(2) synthesis of the bromo- 2- hydroxy benzonitriles of 5-
The bromo- Benzaldehyde,2-hydroxy oximes of 23g 5- are added in 190ml acetic anhydride, stirring 2 hours, concentration is heated to reflux, residue is poured into frozen water, ethyl acetate extraction point liquid is added, organic phase is collected, dry, concentration, cross post separation and obtain the bromo- 2- hydroxy benzonitriles of 16g 5-.
(3) synthesis of 4- ((the bromo- 2- cyano-benzene oxygens of 4-) methyl) piperidines -1- t-butyl formates
The bromo- 2- hydroxy benzonitriles of 15g 5- are added in 180ml tetrahydrofurans, sequentially add 19g 4- (hydroxymethyl) piperidines -1- t-butyl formates, 42g triphenylphosphines, 35g diisopropyl azodiformates, it is stirred at room temperature 24 hours, concentration, silica gel post separation obtains 17g 4- ((the bromo- 2- cyano-benzene oxygens of 4-) methyl) piperidines -1- t-butyl formates on residue.
(4) synthesis of 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates
17g 5- (1- benzyls -1,2,3,6- tetrahydropyridine -4- bases) -2- methylpyrimidines are added in 170ml methyl alcohol, add the palladium carbons of 1g 10%, logical hydrogen, it is stirred at room temperature 24 hours, filters, collects filtrate, concentration, obtains 7g 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates.

Claims (6)

1. a kind of 4 substituted pyridine compound 4- ((2- (amino methyl) -4- bromobenzenes epoxide) methyl) piperidines -1- t-butyl formates Preparation method, with the bromo- Benzaldehyde,2-hydroxies of 5- as initiation material, by oximate, elimination, etherificate, catalytic hydrogenation reaction Target product 5 is obtained, synthetic route is as follows,
2. method according to claim 1, it is characterized by described 4 steps reaction is,
(1) with the bromo- Benzaldehyde,2-hydroxies of 5- as initiation material, 2 are obtained by oximation reaction;
(2) elimination reaction is carried out 2, obtains 3;
(3) carry out etherification reaction 3 and obtain 4;
(4) carry out catalytic hydrogenation reaction 4 and obtain 5;
3. method according to claim 1, it is characterised in that the reagent used by described oximation reaction prepare compound 2 is selected from salt Sour azanol;Reagent used by described elimination reaction prepare compound 3 is selected from the one kind or two in acetic anhydride, POCl3 The mixture planted;Reagent used by described etherification reaction prepare compound 4 is selected from 4- (hydroxymethyl) piperidines -1- formic acid The tert-butyl ester;Catalyst used by described catalytic hydrogenation reaction prepare compound 5 is selected from palladium carbon, palladium dydroxide, Raney's nickel In the mixture of one or more in the mixture of one or more.
4. method according to claim 1, it is characterised in that the solvent used by described oximation reaction prepare compound 2 is selected from first Alcohol, ethanol, normal propyl alcohol, isopropanol, tetrahydrofuran, dichloromethane, toluene, ortho-xylene, paraxylene, two One kind in toluene, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide, triethylamine, pyridine, acetonitrile, acetic acid or Several mixtures;Solvent used by described elimination reaction prepare compound 3 is selected from methyl alcohol, ethanol, normal propyl alcohol, different Propyl alcohol, acetic anhydride, POCl3, tetrahydrofuran, dichloromethane, toluene, ortho-xylene, paraxylene, a diformazan The mixture of one or more in benzene, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide, acetonitrile, water;It is described Etherification reaction prepare compound 4 used by solvent be selected from methyl alcohol, ethanol, normal propyl alcohol, isopropanol, tetrahydrofuran, two The ring of oxygen six, dichloromethane, chloroform, toluene, ortho-xylene, paraxylene, meta-xylene, N, N- dimethyl methyls The mixture of one or more in acid amides, DMAC N,N' dimethyl acetamide, acetonitrile, POCl3;Described catalytic hydrogenation Reaction prepare compound 5 used by solvent be selected from methyl alcohol, ethanol, normal propyl alcohol, isopropanol, tetrahydrofuran, dioxane, Dichloromethane, chloroform, toluene, ortho-xylene, paraxylene, meta-xylene, N,N-dimethylformamide, N, N- The mixture of one or more in dimethylacetylamide, acetic acid, water.
5. method according to claim 1, it is characterised in that the reaction temperature used by described oximation reaction prepare compound 2 is The reflux temperature of 0 DEG C~solvent;Temperature used by described elimination reaction prepare compound 3 is the backflow temperature of 0 DEG C~solvent Degree;Temperature used by described etherification reaction prepare compound 4 is the reflux temperature of 0 DEG C~solvent;Described catalytic hydrogenation Temperature used by reaction prepare compound 5 is the reflux temperature of 0 DEG C~solvent.
6. method according to claim 1, it is characterised in that the reaction temperature used by described oximation reaction prepare compound 2 is Room temperature;Temperature used by described elimination reaction prepare compound 3 is the reflux temperature of solvent;Described etherification reaction system Temperature used by standby compound 4 is room temperature;Temperature used by described catalytic hydrogenation reaction prepare compound 5 is room temperature.
CN201510899842.XA 2015-12-08 2015-12-08 A kind of preparation method of 4 substituted piperidine derivatives Pending CN106854174A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510899842.XA CN106854174A (en) 2015-12-08 2015-12-08 A kind of preparation method of 4 substituted piperidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510899842.XA CN106854174A (en) 2015-12-08 2015-12-08 A kind of preparation method of 4 substituted piperidine derivatives

Publications (1)

Publication Number Publication Date
CN106854174A true CN106854174A (en) 2017-06-16

Family

ID=59132698

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510899842.XA Pending CN106854174A (en) 2015-12-08 2015-12-08 A kind of preparation method of 4 substituted piperidine derivatives

Country Status (1)

Country Link
CN (1) CN106854174A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012136111A1 (en) * 2011-04-02 2012-10-11 中国人民解放军军事医学科学院毒物药物研究所 Phenylpropionic acid compound, preparation method therefor and medicinal use thereof
CN103930416A (en) * 2011-09-09 2014-07-16 默克专利股份公司 Benzonitrile derivatives as kinase inhibitors
CN104520300A (en) * 2012-06-04 2015-04-15 第一三共株式会社 Imidazo[1,2-b]pyridazine derivative as kinase inhibitor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012136111A1 (en) * 2011-04-02 2012-10-11 中国人民解放军军事医学科学院毒物药物研究所 Phenylpropionic acid compound, preparation method therefor and medicinal use thereof
CN103930416A (en) * 2011-09-09 2014-07-16 默克专利股份公司 Benzonitrile derivatives as kinase inhibitors
CN104520300A (en) * 2012-06-04 2015-04-15 第一三共株式会社 Imidazo[1,2-b]pyridazine derivative as kinase inhibitor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
姚其正等: "《药物合成反应》", 30 September 2012 *

Similar Documents

Publication Publication Date Title
CN104974105B (en) The method that one kind prepares 4 (4 aminophenyl) 3 morpholones
CN106905249A (en) A kind of preparation method of azepine class compound
CN106854174A (en) A kind of preparation method of 4 substituted piperidine derivatives
CN106810513A (en) A kind of preparation method of bridged piperazine derivatives
CN107698491A (en) A kind of preparation method of substituted piperidine derivative
CN106986837A (en) A kind of preparation method of azole compounds
CN107778215A (en) A kind of preparation method of fluorine substituted piperidine derivative
CN107778216A (en) A kind of preparation method of fluorine substituted piperidine derivative
CN108117510A (en) A kind of preparation method of piperidine derivative
CN108610309A (en) A kind of preparation method of piperidine derivative
CN107400082A (en) A kind of preparation method of substituted piperidine derivative
CN107286076A (en) A kind of preparation method of piperidines
Mohareb et al. Synthesis of novel tryptophan derivatives of potential biological activity
CN106905282A (en) A kind of preparation method of benzo oxa- ring derivatives
CN107698556A (en) A kind of 2 chlorine 5(The base of piperidines 4)The preparation method of pyrimidine
CN108218753A (en) A kind of preparation method of 2- (4- trifluoromethyl benzyls) pyrrolidines
CN108129434A (en) A kind of preparation method of 5- cyano chroman derivatives
CN107513029A (en) A kind of preparation method of 2 (3 cyanobenzyls) pyrrolidines
CN106831681A (en) A kind of preparation method of 5 nitro pyran derivate
CN107698547A (en) A kind of preparation method of pyran derivate
CN107400106A (en) A kind of preparation method of 5- fluorine pyran derivate
CN107176949A (en) A kind of preparation method of triazole pyrans hydrochloride
CN104341389A (en) Method for preparing triazolylpiperidine hydrochloride
CN106831616A (en) A kind of preparation method of triazole class compounds
CN106883140A (en) A kind of preparation method containing azido micromolecular compound

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170616

RJ01 Rejection of invention patent application after publication